Comparative assessment of alcaftadine and olopatadine for allergic conjunctivitis: a meta-analysis.

Bibliographic Details
Title: Comparative assessment of alcaftadine and olopatadine for allergic conjunctivitis: a meta-analysis.
Authors: Xiaojuan Fu1, Peijie Xu2, Di Lu3 31919599@qq.com
Source: Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii. Dec2024, Vol. 41 Issue 6, p560-565. 6p.
Subject Terms: *ALLERGIC conjunctivitis, *RANDOMIZED controlled trials, *SYMPTOMS, *HETEROGENEITY
Abstract: Introduction: It is unclear to compare the efficacy of alcaftadine versus olopatadine for patients with allergic conjunctivitis, and this meta-analysis aims to perform the comparative assessment of their efficacy for allergic conjunctivitis. Methods: We systematically searched PubMed, Embase, Web of Science, EBSCO, and Cochrane library databases, and included randomized controlled trials (RCTs) comparing alcaftadine with olopatadine for allergic conjunctivitis. The random-effect model was used for the significant heterogeneity, and otherwise the fixed-effect model was used. Results: Twelve RCTs and 1064 patients with allergic conjunctivitis were included in this meta-analysis. In comparison with olopatadine intervention, alcaftadine intervention demonstrated a comparable ocular symptom score on 3 days (MD = -0.06; 95% CI = -0.19 to 0.07; p = 0.35), but was able to significantly decrease the ocular symptom score on 7 days (MD = -0.09; 95% CI = -0.16 to -0.01; p = 0.03), ocular symptom score on 14 days (MD = -0.25; 95% CI = -0.37 to -0.12; p < 0.0001) and conjunctival hyperaemia score on 14 days (MD = -0.04; 95% CI = -0.05 to -0.03; p < 0.00001). These two groups had similar incidence of adverse events (OR = 0.61; 95% CI = 0.34 to 1.09; p = 0.10). Conclusions: Alcaftadine had better capability to treat allergic conjunctivitis compared to olopatadine. [ABSTRACT FROM AUTHOR]
Copyright of Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii is the property of Termedia Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:1642395X
DOI:10.5114/ada.2024.144166
Published in:Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii
Language:English